搜索临床试验以:minimal residue disease
总计380809个结果
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead Company招聘中
-
Fang WuZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Sun Yat-sen University; Cancer... 和其他合作者招聘中
-
Novartis PharmaceuticalsChildren's Oncology Group招聘中B细胞急性淋巴细胞白血病美国, 比利时, 意大利, 瑞典, 荷兰, 挪威, 英国, 德国, 加拿大, 西班牙, 法国, 芬兰, 丹麦
-
M.D. Anderson Cancer Center暂停
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLC主动,不招人
-
Elicio Therapeutics主动,不招人大肠癌 | 卵巢癌 | 胆管癌 | 胆管癌 | 非小细胞肺癌 | 胰腺导管腺癌 | 最小残留病 | 胆囊癌 | 克拉斯G12D | 克拉斯G12R | NRAS G12D | NRAS G12R美国
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的急性淋巴细胞白血病 | 完全血液学缓解 (CHR) | 持续性/复发性微小残留病 (MRD)意大利
-
University of British ColumbiaAmgen终止
-
Astellas Pharma Global Development, Inc.批准上市急性髓系白血病 (AML) | FMS 样酪氨酸激酶 3 (FLT3) 突变美国, 加拿大, 日本
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)撤销
-
Astellas Pharma Global Development, Inc.不再可用急性髓系白血病 (AML) | FMS 样酪氨酸激酶 3 (FLT3) 突变澳大利亚, 意大利, 英国
-
The First Affiliated Hospital of Soochow University尚未招聘多发性骨髓瘤 | 初诊 | MRD | 高风险
-
Air Force Military Medical University, ChinaFirst Affiliated Hospital Xi'an Jiaotong University; Shaanxi Provincial People's Hospital; Second... 和其他合作者尚未招聘
-
Hospital Universitari Vall d'Hebron Research Institute招聘中
-
Exact Sciences CorporationLabcorp Corporation of America Holdings, Inc招聘中
-
Restorear Devices LLCUniversity of Miami; National Institute on Deafness and Other Communication Disorders (NIDCD)尚未招聘
-
AbbVie招聘中
-
M.D. Anderson Cancer CenterBellicum Pharmaceuticals, Inc.尚未招聘
-
Nantes University HospitalJanssen Pharmaceutica尚未招聘
-
Fudan University尚未招聘肺癌 | 最小残留病 | 表皮生长因子受体基因突变
-
Iain BressendorffDitte Hansen MD PhD; Casper Rydahl MD; Anders Nordholm MD PhD; Eva Gravesen MD PhD尚未招聘肾病综合症 | 微小病变 | 膜性肾病 | 原发性局灶节段性肾小球硬化